Impact of parallel trade on pharmaceutical market in Poland
Parallel trade of pharmaceuticals is very complex and controversial phenomenon. It has 9 year history of systematic growth in Poland, however has reached only 1% share of the total Polish pharmaceutical market, so far. Moreover, there is a future risk that the growth of this sector will slow down or even change into negative trend without governmental support and with growing parallel export phenomenon stimulated by new reimbursement act. The results of this research show that there is an instant need for development of mechanisms to control export of Polish pharmaceuticals. Simultaneously, more specific approach is required to stimulate import of drugs in Poland. Both should ensure the right balance of the local pharmaceutical market and proper availability of pharmaceutical products for the Polish patients
